Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Financial risk management (Tables)

v3.23.2
Financial risk management (Tables)
6 Months Ended
Jun. 30, 2023
Disclosure of nature and extent of risks arising from financial instruments [abstract]  
Summary of Nature and Extent of Risks Arising From Financial Instruments
This note explains the Group’s exposure to financial risks and how these risks could affect the Group’s future financial performance.
Risk Exposure arising from Measurement Management
Market risk – interest rate risk Long-term borrowings at variable rates Sensitivity analysis Economic hedge with an interest rate cap
Market risk – price risk Investments in equity securities Sensitivity analysis Monitoring quarterly valuation updates and forecasts of future cash flows
Liquidity risk Borrowings and other liabilities Cash flow forecasts Availability of borrowing facilities.
Summary of Sensitivity Analysis of Fair Value Measurement to Changes in Unobservable Inputs, Liabilities The impact on loss after tax for the six months ended June 30, 2023 and 2022 as a result of a change in interest rates is as follows:
(in €‘000) Impact on pre-tax loss
2023 2022
Interest rates – increase by 10 basis points*
458  227 
Interest rates – decrease by 10 basis points*
(435) (216)
*Keeping all other variables constant.
Summary of Unobservable Input Parameters Used in The Valuation Model
The table below summarizes the impact of increases/decreases of the price of equity securities on the group’s equity through OCI reserve for the period. The analysis is based on the assumption that the fair value of the equity securities held by the group has increased or decreased by 40%, with all other variables held constant.
(in €‘000) Impact on Group's Equity
June 30, 2023
Fair Value – increase by 4000 bp (basis points)
9,925 
Fair Value – decrease by 4000 bp (basis points)
(9,925)
Summary of Undrawn Borrowing Facilities
The Group had access to the following undrawn borrowing facilities for each reporting period presented:
(in €‘000) June 30, 2023 December 31, 2022
Expiring beyond one year—renewed facility 77,390  120,790